Hydroxydaunomycin hydrochloride
Showing 1 - 25 of 1,785
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)
Terminated
- Breast Neoplasms
- Doxorubicin
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 31, 2022
DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)
Completed
- Diffuse Large B-Cell Lymphoma
- High Grade B-Cell Lymphoma
- Venetoclax
- +6 more
-
Boston, Massachusetts
- +5 more
Aug 23, 2022
Richter Syndrome, Chronic Lymphocytic Leukemia Trial in New York (Polatuzumab Vedotin, Rituximab, Etoposide)
Recruiting
- Richter Syndrome
- Chronic Lymphocytic Leukemia
- Polatuzumab Vedotin
- +5 more
-
New York, New YorkWeill Cornell Medicine
Dec 19, 2022
Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)
Not yet recruiting
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Glofitamab
- +5 more
-
Boston, Massachusetts
- +1 more
Apr 4, 2023
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)
Completed
- Lymphoma
- AMG 531
- +8 more
-
Houston, TexasUT MD Anderson Cancer Center
Aug 25, 2021
Breast Cancer, Pregnancy Trial in Houston (5-Fluorouracil, Cyclophosphamide, Doxorubicin)
Completed
- Breast Cancer
- Pregnancy
- 5-Fluorouracil
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 9, 2020
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)
Terminated
- Locally Advanced Sarcoma
- Dexamethasone
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Aug 5, 2021
Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)
Active, not recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +3 more
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)
Completed
- Lymphoma
- Rituximab
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 18, 2020
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
High Grade Upper Tract Urothelial Carcinoma Trial in United States (Methotrexate, Vinblastine, Doxorubicin)
Completed
- High Grade Upper Tract Urothelial Carcinoma
- Methotrexate
- +7 more
-
Birmingham, Alabama
- +133 more
Aug 9, 2022
Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood
Active, not recruiting
- Adult T Acute Lymphoblastic Leukemia
- +7 more
- Bortezomib
- +18 more
-
Birmingham, Alabama
- +211 more
Jan 26, 2022
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023